Addleshaw Goddard’s Post

What was once simply well-supported rumors has now officially turned into confirmation with an investment prospectus, official trading dates, and lots of legacy financial media hype. So, it seems only right that I updated my Applied Nutrition IPO content from earlier this year... And it has been just over 3 years since the last sizable sports/active nutrition brand went public, so this is absolutely an important financial event impacting the global supplement industry...one that could become an important catalyst that builds momentum for similar activity over the next 12-18 months. Based on the min/max of available shares (and expected IPO price range), Applied Nutrition market capitalization will range between $440 million and $520 million. So, with FY24 revenue at ~$121 million (and EBITDA at ~$31.5 million), it would bring the appropriate investment ratios for Applied Nutrition within the midpoint of a direct peer group that includes BellRing Brands, Inc., Glanbia Performance Nutrition (GPN), and Myprotein. But in my latest first principles thinking content, I'll provide you with [all black] everything you need to know about this upcoming IPO 😎 ▪️ Applied Nutrition asset-heavy business model ▪️ Applied Nutrition sales channel expansion ▪️ Applied Nutrition U.S. expansion plans + much more... Finally, I'd like to send my congratulations (and good luck next week) to everyone involved including Thomas Ryder and those team members that I know well within the U.S. subsidiary AN Performance. #strategy #trends #markets #fmcg #cpg #food #beverages #supplements #sportsnutrition #finance #investing #wellness #nutrition #innovation #marketing #branding #productdevelopment #retailing #merchandising #retail #grocery #business #businessintelligence #entrepreneurship https://lnkd.in/gAab46Dk

We're excited to share that Bioniq has closed a $15M Series B funding round, led by HV Capital and Unbound, valuing the company at $75M. This funding will enable us to further expand our global market share by enhancing product development, integrating our global laboratory network, and expanding our operations in the U.S. and the Middle East. We will also implement a corporate platform for medical, wellness, and athletic institutions. Over the past 12 months, we've seen significant growth, especially in the U.S. market, which now accounts for over 50% of our customer base, with some regions experiencing over 500% growth in the last two quarters. "We've entered a new era in nutritional supplementation over the last six years, where it’s clear that one-size-fits-all solutions are inefficient,” said Vadim Fedotov, co-founder & CEO of Bioniq. “Bioniq is committed to providing evidence-driven, personalized solutions that adapt to our users' unique health needs and goals.” "Bioniq's innovative approach to nutrition is based on the idea that everyone has different nutritional needs and deficiencies, and that generic multivitamins are not enough to address them. We are impressed by Bioniq's vision and technology, and we believe that they are disrupting the supplement industry with their personalized and science-based approach. We are excited to support them as they grow and scale their business," said Shravin Bharti Mittal, CEO of Unbound "Bioniq's exceptional growth is a testament to its innovative approach for high quality personalized health solutions that professionals across the world rely on” said David Kuczek, General Partner at HV Capital. “With sales from across 60 countries with the majority coming from North America, one of the most important markets for health solutions globally, Bioniq is well-positioned to continue its trajectory of rapid expansion." Read more about our Series B funding round below! https://lnkd.in/dN4RWpg2

𝗣𝗥𝗘𝗦𝗦 𝗥𝗘𝗟𝗘𝗔𝗦𝗘 | Today we announce that Ardian has signed an agreement to sell its stake in Nutripure, a digital active nutrition brand that provides a comprehensive ecosystem of products and services, including food supplements and sports nutrition, primarily through its own website, to PAI Partners. Since our investment in 2022, Nutripure has strengthen its premium position in the French market and expanded its product portfolio to address a growing and resilient customer base. “𝐼𝑛 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 𝑡ℎ𝑟𝑒𝑒 𝑦𝑒𝑎𝑟𝑠, 𝑁𝑢𝑡𝑟𝑖𝑝𝑢𝑟𝑒 ℎ𝑎𝑠 𝑚𝑜𝑟𝑒 𝑡ℎ𝑎𝑛 𝑞𝑢𝑎𝑑𝑟𝑢𝑝𝑙𝑒𝑑 𝑖𝑡𝑠 𝑡𝑢𝑟𝑛𝑜𝑣𝑒𝑟, 𝑤ℎ𝑖𝑙𝑒 𝑎𝑐ℎ𝑖𝑒𝑣𝑖𝑛𝑔 𝑎𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑣𝑒 𝑟𝑒𝑐𝑟𝑢𝑖𝑡𝑚𝑒𝑛𝑡 𝑎𝑛𝑑 𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ𝑒𝑛𝑖𝑛𝑔 𝑡ℎ𝑒 𝑡𝑜𝑝 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡. 𝐼𝑡 ℎ𝑎𝑠 𝑏𝑒𝑒𝑛 𝑎 𝑔𝑟𝑒𝑎𝑡 𝑝𝑙𝑒𝑎𝑠𝑢𝑟𝑒 𝑡𝑜 𝑤𝑜𝑟𝑘 𝑎𝑙𝑜𝑛𝑔𝑠𝑖𝑑𝑒 𝑡ℎ𝑒𝑚 𝑎𝑛𝑑 𝑡ℎ𝑒 𝑒𝑛𝑡𝑖𝑟𝑒 𝑁𝑢𝑡𝑟𝑖𝑝𝑢𝑟𝑒 𝑡𝑒𝑎𝑚, 𝑙𝑒𝑣𝑒𝑟𝑎𝑔𝑖𝑛𝑔 𝑜𝑢𝑟 𝑐𝑟𝑜𝑠𝑠-𝑣𝑒𝑟𝑡𝑖𝑐𝑎𝑙 𝑒𝑥𝑝𝑒𝑟𝑡𝑖𝑠𝑒 𝑖𝑛 𝑒-𝑐𝑜𝑚𝑚𝑒𝑟𝑐𝑒 𝑎𝑛𝑑 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑡𝑜 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝑡ℎ𝑒 𝑐𝑜𝑚𝑝𝑎𝑛𝑦'𝑠 𝑠𝑐𝑎𝑙𝑖𝑛𝑔 𝑎𝑛𝑑 𝑠𝑢𝑠𝑡𝑎𝑖𝑛 𝑖𝑡𝑠 𝑟𝑒𝑚𝑎𝑟𝑘𝑎𝑏𝑙𝑒 𝑔𝑟𝑜𝑤𝑡ℎ.” Frédéric Quéru, Managing Director, Growth, Ardian Read more in the press release → https://bit.ly/4fgdUca #PrivateEquity #Growth #SuccessStory #GrowthStory #HealthWellness #Nutrition Niccolo Saligari

Esoteric Testing Market to Generate a Revenue of USD 8.2 billion by 2027 Download PDF Brochure@https://lnkd.in/dFfvZFtt The global enteral feeding formulas market in terms of revenue was estimated to be worth $5.2 billion in 2022 and is poised to reach $8.2 billion by 2027, growing at a CAGR of 9.5% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Abbott Nestlé Danone Fresenius Kabi BKK B. Braun Melsungen AG Otsuka Holdings Co., Ltd. Nutritional Medicinals, LLC Kate Farms Medtrition, Inc. Victus, Inc. Global Health Products, Inc. MEIJI Holdings Co Ltd., Reckitt Hormel Foods DermaRite Medline Industries, LP Real Food Blends Ajinomoto Cambrooke, Inc.

The lovely Lynda Doyle joined me to discuss what she's witnessed the past 34 years in the industry. She went from operating in a 'boys' club' to becoming secretary of Women In Nutraceuticals. The dietary supplement industry that was once considered 'fringe' is now mainstream. Check out her insights here: Avant Nutrition, LLC NutraIngredients-usa #dietarysupplements #nutrawomen #NWW #wellnesswednesday #womeninconsulting #womenentrepreneurship

Headlining this week's CHC Newsflash: TPG and Blackstone have partnered to work on a joint bid for Bausch + Lomb, according to the UK Financial Times, citing people familiar with the matter. The newspaper reported last month that the eye care business was working with Goldman Sachs advisers to explore a sale. This attracted interest from other private equity groups including Advent International, KKR, CVC Capital and Hellman & Friedman, although they have dropped out of the running, according to sources. Private Equity is becoming the dominant player in our industry’s M&A. I’ve spoken to several firms in the past few weeks, who tell a similar story: healthcare is an important growth pillar, but most are underweight in consumer health and with a little gentle persuasion can readily see our charms. Now TPG and Blackstone are looking to make a bid for Bausch’s eyecare subsidiary, while CD&R and PAI are scrapping over who will take majority control of Sanofi’s CHC business. With very few exceptions, M&A doesn’t grow the market, those exceptions being related to companies with underdeveloped or neglected brands – and we see plenty of those in our own M&A boutique. Financial institutions bring rigour to the companies they own, but this often involves cutting out longer-term NPD, especially Rx-to-OTC Switch, and brand-building. But where PE excels is using a “buy to build” strategy to give a marketer international scale. Cooper is a fine example, and its PE owner CVC championed the acquisition of the Viatris OTC business which has put Cooper on the European map in a substantial way. But Private Equity is not a long-term market builder. For that we have to search for a different type of company, such as Valbiotis, which launched its first product in 2024 after many years of basic research. This truly innovative product is a 100% natural dietary supplement for the management of mild-to-moderate LDL hypercholesterolemia and is a good example of what the future holds for evidence-based VMS brands. To quote co-founder Sébastien PELTIER: “Valbiotis has all the attributes to … establish itself as a future European champion in 100% plant-based dietary supplements with strong scientific credentials.” It is not surprising that the company is in advanced discussions with a view to signing international licensing agreements with players in the nutrition and healthcare sectors. Bringing these to a successful conclusion will be a template for serious competitors at the cutting edge of VMS. To read more of my thoughts on this and other key CHC trends and developments, trial our combined news service by contacting Melissa #consumerhealthcare #CHC #CHCNewsflash #CHCNewDirections #Valbiotis #BauschLomb #TPG #Blackstone #privateequity

🚀 Unlocking Success in Nutraceuticals, Dietary Supplements, Functional F&B, and Cosmeceuticals! 🚀 I'm thrilled to share we are expanding with amny new customers. If you are a producers, brand, consulting firms, VCs, and PEs looking to excel in the dietary supplements, nutraceuticals, functional F&B, or cosmeceuticals spaces, let's connect! Together, we can navigate the complexities and unlock new opportunities.. What We Offer: 🔹 Strategic Planning – Crafting bespoke strategies to drive your business forward. 🔹 Investor Relations – Connecting you with potential investors and supporting your fundraising efforts. 🔹 Business Development – Opening doors, forging partnerships, and propelling your growth. 🔹 Distribution Channels – Establishing and optimizing channels to enhance market reach. 🔹 Advisory Roles – Providing expert guidance as a fractional CEO, board member, and advisor. If you're l If you are looking to make a mark in these dynamic industries, feel free to reach out for a conversation! #Consulting #Nutraceuticals #DietarySupplements #FunctionalFood #Cosmeceuticals #BusinessDevelopment #StrategicPlanning #InvestorRelations #Distribution

Founded in September 2020, Origins Nutra is on a mission to revolutionize preventative healthcare for chronic diseases such as cholesterol and diabetes. With a comprehensive approach that includes health supplements, expert consultations, and educational content, Origins Nutra is empowering health-conscious individuals to take proactive steps towards better health. Dr. Rajani Chinni and Surya Tej Chinni, the founders of Origins Nutra, identified a crucial gap in the market. Coming from a family deeply rooted in pharma and nutraceuticals, they recognized the need for an evidence-based approach to preventative healthcare. Their vision materialized in the form of Origins Nutra, which bridges this gap by offering high-quality supplements designed to fill dietary nutrient gaps and support energy and recovery, especially for athletes. Origins Nutra’s product range includes one-a-day tablets, capsules, and soft gels, made with clinically-sourced ingredients like ashwagandha, lichen extracts, and algal calcium. The startup takes pride in its in-house manufacturing capabilities, ensuring quality and consistency in every product. To cater to the diverse needs of its customers, Origins Nutra provides a product recommendation quiz and access to over 200 health experts for personalized consultations. This customer-centric approach has contributed to the company’s impressive growth, with a 20% month-over-month increase and an average monthly revenue of INR 11 Lakh. Notably, the company enjoys a 35% repeat customer rate, reflecting high customer satisfaction and loyalty. In December 2023, Origins Nutra underwent a rebranding and launched several new products, further strengthening its market position. Looking ahead, the focus for 2024 is on expanding the community of health experts to over 500 and serving more than 30,000 customers. Origins Nutra’s journey is a testament to the power of innovative thinking and a commitment to health and well-being. As the startup continues to grow, it remains dedicated to providing effective, science-backed solutions for preventative healthcare. #PreventativeHealthcare #ChronicDiseasePrevention #HealthSupplements #OriginsNutra #Entrepreneurship #HealthAndWellness #Startups #Innovation #Pharma #Nutraceuticals #HealthyLiving #SEONews

𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐕𝐢𝐭𝐚𝐦𝐢𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 2023-2031 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐃𝐞𝐦𝐨 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐄𝐱𝐜𝐞𝐥 𝐏𝐢𝐯𝐨𝐭 𝐚𝐧𝐝 𝐓𝐨𝐂: https://lnkd.in/dUPm7Gqd The #PersonalizedVitamins Market Size is valued at USD 10.20 Bn in 2023 and is predicted to reach USD 33.28 Bn by the year 2031 at an 16.2% CAGR during the forecast period for 2024-2031. ▪ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞: ▪ BASF ▪ Abbott ▪ Amway ▪ Bayer Consumer Care AG ▪ Caligenix® ▪ DayTwo ▪ DNAfit ▪ DSM ▪ Nutrigenomix® ▪ Elysium Healthcare ▪ Genomix ▪ GSK ▪ GNC ▪ Habit Food Group ▪ Lonza ▪ InsideTracker ▪ LifeDNA ▪ Metagenics ▪ The Nature's Bounty Co. ▪ Nature's Way Bird Products, LLC ▪ Nestlé Health Science ▪ Persona ▪ Ritual ▪ Rootine ▪ Telomere Diagnostics, Inc. ▪ Truvani ▪ Youtheory #HealthSupplements #MarketTrends #DosageForms #Wellness #Fitness #DirectToConsumer #2023to2031 #NutritionalSupplements

First batch of companies attending Compete Forward program have successfully completed it. Blagoleks, a small family-owned company with 12 employees, has been a notable player in the cosmetics and dietary supplements industry since its inception. It's known for its brands Lifeline and Linoderm, and is lead by Ivana Popović. Company is undergoing a digital transformation and a shift to D2C (direct to consumer) business model. Here comes Ivana's comment related to the program: "Thanks to the very kind and cooperative employees of SEEBA, I went through the BizEngine application, which aimed to determine the business health of the company I manage. The result of the analysis is a rather extensive report with an extensive content guidelines for further business development aimed at sustainable growth." Read more about this case study https://lnkd.in/drUrtavd The Compete Forward program is funded by Challenge to Change project, Swedish government and its partners SERDA and EDA. 🇸🇪